Erythropoietic factor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 22, 1991
Grant Date -
N/A
app pub date -
May 27, 1988
filing date -
May 27, 1988
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method for treating anemia comprises administering an atrial natriuretic factor (ANF) alone or in combination with erythropoietin (Epo). The ANF potentiates the activity of Epo and causes production of erythroid progenitors, BFU-E and CFU-E, and as a consequence red blood cell production at greater levels than if Epo alone is present in the blood stream.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully